AI imaging test to find skin cancer edges before surgery
Part of Cancer clinical trials.
This trial uses an advanced AI-assisted imaging device to see the edges of a common skin cancer called basal cell carcinoma before surgery. It may help doctors remove the cancer more precisely, possibly reducing the need for repeat procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have at least one confirmed superficial or nodular type of basal cell carcinoma
- You are willing to let the study team take photos of the treatment area
- You are willing to sign a consent form
- You do not have an active cold sore or herpes infection in the treatment area
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
This study uses artificial intelligence to help diagnose basal cell carcinoma, a common type of skin cancer, from digital images of tissue samples. It may improve accuracy and speed of diagnosis.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests a new imaging tool called LC-OCT to see if it helps doctors remove all skin cancer during Mohs surgery. It might reduce the need for extra surgeries by giving clearer pictures in real time.
Hear when a new Basal Cell Carcinoma of Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.